TY - JOUR
T1 - Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening
AU - Sorop, Oana
AU - Heinonen, Ilkka
AU - van Kranenburg, Matthijs
AU - van de Wouw, Jens
AU - de Beer, Vincent J.
AU - Nguyen, Isabel T. N.
AU - Octavia, Yanti
AU - van Duin, Richard W. B.
AU - Stam, Kelly
AU - van Geuns, Robert-Jan
AU - Wielopolski, Piotr A.
AU - Krestin, Gabriel P.
AU - van den Meiracker, Anton H.
AU - Verjans, Robin
AU - van Bilsen, Marc
AU - Danser, A. H. Jan
AU - Paulus, Walter J.
AU - Cheng, Caroline
AU - Linke, Wolfgang A.
AU - Joles, Jaap A.
AU - Verhaar, Marianne C.
AU - van der Velden, Jolanda
AU - Merkus, Daphne
AU - Duncker, Dirk J.
N1 - Funding Information:
This study was supported by grants from the European Commission FP7-Health-2010 grant MEDIA-261409, the Netherlands CardioVascular Research Initiative: an initiative with support of the Dutch Heart Foundation [CVON2011-11 (ARENA), CVON2012-08 (PHAEDRA), CVON2014-11 (RECONNECT)] and The Academy of Finland 251272, Finnish Diabetes Research Foundation, and Finnish Foundation for Cardiovascular Research.
Publisher Copyright:
© Published on behalf of the European Society of Cardiology. All rights reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Rationale: More than 50% of patients with heart failure have preserved ejection fraction characterized by diastolic dysfunction. The prevalance of diastolic dysfunction is higher in females and associates with multiple comorbidities such as hypertension (HT), obesity, hypercholesterolemia (HC) and diabetes mellitus (DM), although its pathophysiology remains incompletely understood. It has been proposed that the co-morbidities induce systemic inflammation, cardiac microvascular dysfunction and oxidative stress, leading to myocardial fibrosis, myocyte stiffening and ultimately, diastolic dysfunction.Objective: Here we tested this hypothesis in a swine model chronically exposed to three common comorbidities.Methods and Results: - DM (induced by streptozotocin), HC (high fat diet) and HT (resulting from renal artery embolization), (DM+HC+HT) were produced in ten female swine, which were followed for 6 months. Eight female healthy swine on normal pig-chow served as controls. The DM+HC+HT group showed hyperglycemia, hypercholesterolemia, hypertriglyceridemia and hypertension, which were associated with systemic inflammation, renal dysfunction and impaired coronary small artery endothelium-dependent vasodilation. Myocardial superoxide production was markedly increased, due to increased NOX activity and eNOS uncoupling, and associated with reduced NO production. These abnormalities were accompanied by increased myocardial collagen content, reduced capillary/fiber ratio and elevated passive cardiomyocyte stiffness, resulting in a reduced E/A ratio (measured by cardiac MRI), and increased left ventricular end-diastolic stiffness (measured by pressure-volume catheter), while ejection fraction was maintained.Conclusions: - The combination of three common comorbidities leads to systemic inflammation, myocardial oxidative stress and coronary microvascular dysfunction, which associate with myocardial stiffening and LV diastolic dysfunction with preserved ejection fraction.
AB - Rationale: More than 50% of patients with heart failure have preserved ejection fraction characterized by diastolic dysfunction. The prevalance of diastolic dysfunction is higher in females and associates with multiple comorbidities such as hypertension (HT), obesity, hypercholesterolemia (HC) and diabetes mellitus (DM), although its pathophysiology remains incompletely understood. It has been proposed that the co-morbidities induce systemic inflammation, cardiac microvascular dysfunction and oxidative stress, leading to myocardial fibrosis, myocyte stiffening and ultimately, diastolic dysfunction.Objective: Here we tested this hypothesis in a swine model chronically exposed to three common comorbidities.Methods and Results: - DM (induced by streptozotocin), HC (high fat diet) and HT (resulting from renal artery embolization), (DM+HC+HT) were produced in ten female swine, which were followed for 6 months. Eight female healthy swine on normal pig-chow served as controls. The DM+HC+HT group showed hyperglycemia, hypercholesterolemia, hypertriglyceridemia and hypertension, which were associated with systemic inflammation, renal dysfunction and impaired coronary small artery endothelium-dependent vasodilation. Myocardial superoxide production was markedly increased, due to increased NOX activity and eNOS uncoupling, and associated with reduced NO production. These abnormalities were accompanied by increased myocardial collagen content, reduced capillary/fiber ratio and elevated passive cardiomyocyte stiffness, resulting in a reduced E/A ratio (measured by cardiac MRI), and increased left ventricular end-diastolic stiffness (measured by pressure-volume catheter), while ejection fraction was maintained.Conclusions: - The combination of three common comorbidities leads to systemic inflammation, myocardial oxidative stress and coronary microvascular dysfunction, which associate with myocardial stiffening and LV diastolic dysfunction with preserved ejection fraction.
KW - Translational studies
KW - Coronary circulation
KW - Oxidant stress
KW - Endothelium/nitric oxide
KW - Heart failure
KW - Coronary Circulation
KW - Coronary Artery Disease/etiology
KW - Diastole
KW - Oxidative Stress
KW - Ventricular Function, Left
KW - Comorbidity
KW - Hypercholesterolemia/complications
KW - Risk Factors
KW - Hypertension, Renovascular/complications
KW - Diabetes Mellitus, Experimental/complications
KW - Stroke Volume
KW - Microcirculation
KW - Animals
KW - Myocardium/metabolism
KW - Fibrosis
KW - Female
KW - Sus scrofa
KW - Ventricular Dysfunction, Left/etiology
KW - Coronary Vessels/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85048060835&partnerID=8YFLogxK
U2 - 10.1093/cvr/cvy038
DO - 10.1093/cvr/cvy038
M3 - Article
C2 - 29432575
SN - 0008-6363
VL - 114
SP - 954
EP - 964
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 7
ER -